Ferd increases stake in Pronova Bio

Ferd Private Equity has acquired the remaining shares in Norwegian pharmaceutical company Pronova Biocare. Ferd originally acquired an 80.1% stake in the company in December 2003 for NOK 165m and at the same time secured a loan of NOK 225, which has now been repaid. Pronova Biocare is a world leader in the development, production and sale of marine Omega-3 fatty acids. The company's business is sub-divided into three business areas: pharmaceuticals, consumer brands and industrial brands.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Nordics
• Industrials